Industry: Pharmaceuticals, Biotechnology
Biomethodes SA, Biotech Company specialised in directed molecular evolution, has developed the first combinatorial high throughput site directed mutagenesis technology: Massive Mutagenesis®. This proprietary technology was used in over 20 research partnerships in France and abroad (including GlaxoSmithKline and Roquette). ( www.biomethodes.com )
Biomethodes SA
One Broadway 14Th Floor
Cambridge, Massachusetts 02142
USA
Tel: (617) 583-1350
Fax: (617) 758-4101